HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,152,000 | -13.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $1,331,000 | +65.3% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $805,000 | -52.8% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $1,705,000 | -16.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2015 | $2,045,000 | -10.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2015 | $2,280,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 190,000 | $570,000 | 0.87% |
| FutureAdvisor, Inc. | 6,606 | $323,000 | 0.11% |
| WEDBUSH SECURITIES INC | 75,000 | $19,000 | 0.00% |
| Virtu KCG Holdings LLC | 330,323 | $83,000 | 0.00% |
| Joel Isaacson & Co., LLC | 15,500 | $4,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 104,750 | $26,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,396 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 236,866 | $59,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $224,000 | 0.00% |